Clearmind MedicineCMND
13F holders, Q1 2025 (March 31)7holders −2
1new positions
3sold out
1famous investor
$9.06avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, down 2 from Q4 2024. 1 opened new positions and 3 sold out. The largest holders were Gotham Asset Management ($5.2M), AdvisorShares Investments LLC ($228K) and Cornerstone Wealth Group, LLC ($21K). One famous investor held it Joel Greenblatt (0.0% of Gotham Asset Management's portfolio).
- Company
- Clearmind Medicine Inc.
- CUSIP
- 185053402
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 3 | $108K |
All 13F filers, Q4 2024 → Q1 2025: 67,543 shares bought and 78,572 shares sold, net −11,029 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Gotham Asset Management | 0.04% | Add +0.2% | 343,427 | $5.2M |
| AdvisorShares Investments LLC | 0.04% | Add +31.6% | 220,933 | $228K |
| Cornerstone Wealth Group, LLC | 0.00% | No change | 20,000 | $21K |
| Two Sigma Securities, LLC | 0.00% | New | 13,903 | $14K |
| Morgan Stanley | 0.00% | No change | 2,564 | $3K |
| Royal Bank of Canada | 0.00% | No change | 569 | $1K |
| National Bank of Canada | 0.00% | No change | 379 | $390 |
"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.